Matches in Nanopublications for { ?s ?p "[The expression of PPARG2, RB1, CCND3 and LPL in thigh but not in abdomen scAT was significantly reduced (67%, 25%, 38% and 66% respectively) in patients with FPLD2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 14 of
14
with 100 items per page.
- NP739939.RAcerGNfVNnFCpWN52mR1GTPKAVViL93TAhWqG8qZ_im8130_assertion description "[The expression of PPARG2, RB1, CCND3 and LPL in thigh but not in abdomen scAT was significantly reduced (67%, 25%, 38% and 66% respectively) in patients with FPLD2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP739939.RAcerGNfVNnFCpWN52mR1GTPKAVViL93TAhWqG8qZ_im8130_provenance.
- NP599337.RAwrN9rc9KH2pSbpP3pdoFJAQdfbt8pVTazgisuFMmejs130_assertion description "[The expression of PPARG2, RB1, CCND3 and LPL in thigh but not in abdomen scAT was significantly reduced (67%, 25%, 38% and 66% respectively) in patients with FPLD2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP599337.RAwrN9rc9KH2pSbpP3pdoFJAQdfbt8pVTazgisuFMmejs130_provenance.
- assertion description "[The expression of PPARG2, RB1, CCND3 and LPL in thigh but not in abdomen scAT was significantly reduced (67%, 25%, 38% and 66% respectively) in patients with FPLD2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP288216.RAR345hCNIo-hap_BmcI9gHlkxeGSrLtztOntJjWJHrfo130_assertion description "[The expression of PPARG2, RB1, CCND3 and LPL in thigh but not in abdomen scAT was significantly reduced (67%, 25%, 38% and 66% respectively) in patients with FPLD2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP288216.RAR345hCNIo-hap_BmcI9gHlkxeGSrLtztOntJjWJHrfo130_provenance.
- NP539574.RAVk9af2SYKRaSYXBbDlvWRgedaHJ3uh9sRVpfTqOLRvM130_assertion description "[The expression of PPARG2, RB1, CCND3 and LPL in thigh but not in abdomen scAT was significantly reduced (67%, 25%, 38% and 66% respectively) in patients with FPLD2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP539574.RAVk9af2SYKRaSYXBbDlvWRgedaHJ3uh9sRVpfTqOLRvM130_provenance.
- NP562985.RAJNY40cDIxkfRvmiY5MMSWxFdXQtn-mzeEloZkQTfyJE130_assertion description "[The expression of PPARG2, RB1, CCND3 and LPL in thigh but not in abdomen scAT was significantly reduced (67%, 25%, 38% and 66% respectively) in patients with FPLD2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP562985.RAJNY40cDIxkfRvmiY5MMSWxFdXQtn-mzeEloZkQTfyJE130_provenance.
- assertion description "[The expression of PPARG2, RB1, CCND3 and LPL in thigh but not in abdomen scAT was significantly reduced (67%, 25%, 38% and 66% respectively) in patients with FPLD2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The expression of PPARG2, RB1, CCND3 and LPL in thigh but not in abdomen scAT was significantly reduced (67%, 25%, 38% and 66% respectively) in patients with FPLD2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP694197.RAAWBgm7UCyByFoBsm7R4AeRt0uCmi6DvJlcbtGsbYbZQ130_assertion description "[The expression of PPARG2, RB1, CCND3 and LPL in thigh but not in abdomen scAT was significantly reduced (67%, 25%, 38% and 66% respectively) in patients with FPLD2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP694197.RAAWBgm7UCyByFoBsm7R4AeRt0uCmi6DvJlcbtGsbYbZQ130_provenance.
- NP532962.RAI3gEZcvGeg3RP9VcWWNB6ghoXuKaxRkXeFQwWvQTLKY130_assertion description "[The expression of PPARG2, RB1, CCND3 and LPL in thigh but not in abdomen scAT was significantly reduced (67%, 25%, 38% and 66% respectively) in patients with FPLD2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP532962.RAI3gEZcvGeg3RP9VcWWNB6ghoXuKaxRkXeFQwWvQTLKY130_provenance.
- NP638042.RA22T3lfW2qMVdX9oK4jbtZnDFa2AZZqZ7XvALYl4CE2c130_assertion description "[The expression of PPARG2, RB1, CCND3 and LPL in thigh but not in abdomen scAT was significantly reduced (67%, 25%, 38% and 66% respectively) in patients with FPLD2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP638042.RA22T3lfW2qMVdX9oK4jbtZnDFa2AZZqZ7XvALYl4CE2c130_provenance.
- NP694195.RAGgVZkpvwtfoZ8J0vUFMLlo3RuCuYHUCallTP0sDcLBQ130_assertion description "[The expression of PPARG2, RB1, CCND3 and LPL in thigh but not in abdomen scAT was significantly reduced (67%, 25%, 38% and 66% respectively) in patients with FPLD2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP694195.RAGgVZkpvwtfoZ8J0vUFMLlo3RuCuYHUCallTP0sDcLBQ130_provenance.
- NP694199.RAH5cw68mqwWmdLzYa-iahgZBr4rx8WjHLg8AMvrMskLA130_assertion description "[The expression of PPARG2, RB1, CCND3 and LPL in thigh but not in abdomen scAT was significantly reduced (67%, 25%, 38% and 66% respectively) in patients with FPLD2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP694199.RAH5cw68mqwWmdLzYa-iahgZBr4rx8WjHLg8AMvrMskLA130_provenance.
- NP694198.RA-MgAnehqXFMV2eAN05F3w2wNDfEyQ2SVHii-8pyue9A130_assertion description "[The expression of PPARG2, RB1, CCND3 and LPL in thigh but not in abdomen scAT was significantly reduced (67%, 25%, 38% and 66% respectively) in patients with FPLD2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP694198.RA-MgAnehqXFMV2eAN05F3w2wNDfEyQ2SVHii-8pyue9A130_provenance.